Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patie… (NCT07468110) | Clinical Trial Compass
RecruitingNot Applicable
Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke
Turkey (Türkiye)47 participantsStarted 2026-03-10
Plain-language summary
The primary aim of this study is to evaluate the relationship between the CONUT score, which reflects nutritional status, and balance performance in patients with chronic stroke. The secondary aims are to investigate the association between the CONUT score and functional status and stroke-specific quality of life, as well as to assess the relationships of mid-upper arm circumference, an anthropometric indicator of nutritional status, and ultrasonographic rectus femoris muscle thickness, which reflects muscle mass, with balance performance, functional status, and stroke-specific quality of life. In addition, the study aims to examine the relationships between bone mineral density and balance, functional status, and ambulation level in patients with chronic stroke.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being 18 years of age or older
* Having a diagnosis of ischemic or hemorrhagic stroke
* At least 6 months having elapsed since the stroke event (chronic phase)
* Being clinically stable
* Being able to participate in standing and balance assessments (walking with an assistive device is acceptable)
* Having sufficient cognitive capacity to understand and respond to the assessment scales used in the study
* Voluntarily agreeing to participate in the study and providing written informed consent
Exclusion Criteria:
* Acute or subacute stroke phase (\< 6 months)
* Inability to administer assessment scales due to severe cognitive impairment or aphasia
* Presence of other neurological disorders that may significantly affect balance and functional status (e.g., Parkinson's disease, multiple sclerosis, peripheral neuropathy)
* Significant orthopedic conditions unrelated to stroke (e.g., advanced hip or knee osteoarthritis, lower extremity amputation)
* Presence of active infection, malignancy, or systemic inflammatory disease (as these conditions may affect the CONUT score)
* Cerebellar localization of the cerebrovascular event
* History of major surgery or intensive care unit admission within the past 3 months
* Inability to safely perform balance tests due to severe visual or hearing impairment
* Patients with incomplete laboratory data or insufficient information to calculate the CONUT score
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.